Revcovi: payments to doctors
Payments that named Revcovi as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $197K
- Providers
- 49
- Transactions
- 115
- Average per transaction
- $1,712
The per-transaction average — $1,712 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 49 providers the average total is $4,017, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Chiesi USA, Inc. | $149,201 | 75.8% |
| Leadiant Biosciences, Inc. | $47,622 | 24.2% |